Concepedia

Elizabeth Thurgar

ET

Statistics

Publications

1

Citations

36

H-Index

1

Active since

2021

Affiliations

Merck Canada Inc. (Canada)(Current)

Elizabeth Thurgar is an author at Merck Canada Inc. (Canada) specializing in cost-effectiveness analysis, cost-effectiveness, and cancer survival analysis.

Publications per year

2021–2021

1

Publications

1

Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer

Elizabeth Thurgar, Mark Gouldson, Suzette M. Matthijsse et al. · Journal of Medical Economics · 2021 · 36 citations · Full text

, , +16

1–1 of 1